Close
  Indian J Med Microbiol
 

Figure 1: Differential expression levels of EPOR mRNA in breast cancer patients based on different kinds of classified parameters. (A) TCGA data revealed that EPOR mRNA was significantly lower in breast cancer tissues (1 085 cases) than that in normal tissues (291 cases); (B-J) differential expression levels of EPOR mRNA in breast cancer patients were performed by bc-GenExMiner v4.1 based on different kinds of classified parameters: ER+ vs. ER- (B), PR+ vs. PR- (C), HER2+ vs. HER2- (D), N+ vs. N- (E), NPI1 vs. NPI2 vs. NPI3 (F), SBR1 vs. SBR2 vs. SBR3 (G), Basal-like vs. Not basal-like (H), Basal-like and TNBC vs. Not basal-like and not TNBC (I), TNBC vs. Not TNBC (J).

Figure 1: Differential expression levels of EPOR mRNA in breast cancer patients based on different kinds of classified parameters.
(A) TCGA data revealed that EPOR mRNA was significantly lower in breast cancer tissues (1 085 cases) than that in normal tissues (291 cases); (B-J) differential expression levels of EPOR mRNA in breast cancer patients were performed by bc-GenExMiner v4.1 based on different kinds of classified parameters: ER+ <i>vs</i>. ER- (B), PR+ <i>vs</i>. PR- (C), HER2+ <i>vs</i>. HER2- (D), N+ <i>vs</i>. N- (E), NPI1 <i>vs</i>. NPI2 <i>vs</i>. NPI3 (F), SBR1 <i>vs</i>. SBR2 <i>vs</i>. SBR3 (G), Basal-like <i>vs</i>. Not basal-like (H), Basal-like and TNBC <i>vs</i>. Not basal-like and not TNBC (I), TNBC <i>vs</i>. Not TNBC (J).